Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $96.38 million. The enterprise value is $38.21 million.

Market Cap	96.38M
Enterprise Value	38.21M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

Immunic has 90.08 million shares outstanding. The number of shares has increased by 101.53% in one year.

Current Share Class	90.08M
Shares Outstanding	90.08M
Shares Change (YoY)	+101.53%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.25%
Owned by Institutions (%)	28.48%
Float	52.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.34
P/TBV Ratio	2.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.02.

Current Ratio	2.71
Quick Ratio	2.56
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -216.24% and return on invested capital (ROIC) is -130.20%.

Return on Equity (ROE)	-216.24%
Return on Assets (ROA)	-90.90%
Return on Capital (ROIC)	-130.20%
Revenue Per Employee	n/a
Profits Per Employee	-$1.26M
Employee Count	77
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.94% in the last 52 weeks. The beta is 1.88, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.88
52-Week Price Change	+0.94%
50-Day Moving Average	1.42
200-Day Moving Average	1.34
Relative Strength Index (RSI)	31.42
Average Volume (20 Days)	931,659

Short Selling Information

The latest short interest is 4.50 million, so 4.99% of the outstanding shares have been sold short.

Short Interest	4.50M
Short Previous Month	3.47M
Short % of Shares Out	4.99%
Short % of Float	8.54%
Short Ratio (days to cover)	4.66

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-95.80M
Pretax Income	-95.31M
Net Income	-96.90M
EBITDA	-95.68M
EBIT	-95.80M
Earnings Per Share (EPS)	-$1.12

Full Income Statement

Balance Sheet

The company has $59.07 million in cash and $899,000 in debt, giving a net cash position of $58.17 million or $0.65 per share.

Cash & Cash Equivalents	59.07M
Total Debt	899,000
Net Cash	58.17M
Net Cash Per Share	$0.65
Equity (Book Value)	41.22M
Book Value Per Share	0.46
Working Capital	39.91M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.83 million and capital expenditures -$426,000, giving a free cash flow of -$76.26 million.

Operating Cash Flow	-75.83M
Capital Expenditures	-426,000
Free Cash Flow	-76.26M
FCF Per Share	-$0.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-101.53%
Shareholder Yield	-101.53%
Earnings Yield	-101.97%
FCF Yield	-80.24%

Analyst Forecast

The average price target for Immunic is $13.20, which is 1,133.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.20
Price Target Difference	1,133.65%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1